MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway

被引:17
作者
Huang, Qingli [1 ]
Hou, Sen [2 ]
Zhu, Xiuqing [3 ]
Liu, Shouzhou [1 ]
机构
[1] Liaocheng Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China
[2] Yanggu Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
[3] Chiping Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
关键词
miR-192; Nasopharyngeal carcinoma; RB1; PI3K; AKT pathway; CELL-PROLIFERATION; RETINOBLASTOMA PROTEIN; MIR-192; SUPPRESSES; TUMOR-SUPPRESSOR; CANCER CELLS; METASTASIS; INVASION; GROWTH; APOPTOSIS; PROGRESSION;
D O I
10.1186/s12957-020-1798-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The dysregulation of microRNAs (miRNAs) has been found in diseases and cancers, including microRNA-192 (miR-192). This study was designed to investigate the role of miR-192 in nasopharyngeal carcinoma (NPC) progression. Methods The expression levels of miR-192 and some genes were assessed by qRT-PCR and Western blot. The function of miR-192 was investigated through MTT, Transwell, and dual-luciferase reporter assays. Results The expression of miR-192 was increased in NPC tissues, and high miR-192 expression predicted poor prognosis in NPC patients. Functionally, upregulation of miR-192 promoted NPC cell migration, invasion, and growth. Furthermore, miR-192 activated EMT and PI3K/AKT pathway to regulate NPC progression. In addition, miR-192 directly targeted RB1 and suppressed its expression in NPC. Moreover, overexpression of RB1 weakened the promoted effect of miR-192 in NPC. Conclusion miR-192 promoted cell viability and metastasis in NPC through suppressing RB1 expression and activating PI3K/AKT pathway.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway
    Qingli Huang
    Sen Hou
    Xiuqing Zhu
    Shouzhou Liu
    World Journal of Surgical Oncology, 18
  • [2] MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway
    Zhang, Yuanyuan
    Zhang, Hui
    Li, Xiuguo
    JOURNAL OF BUON, 2020, 25 (03): : 1579 - 1586
  • [3] HOXC10 promotes nasopharyngeal carcinoma cell proliferation and migration by regulating PI3K/AKT pathway
    Wu, Liping
    Qian, Guohong
    Zheng, Yuqing
    Zheng, Huizhen
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (08) : 1595 - 1600
  • [4] MicroRNA-758 acts as a tumor inhibitor in colorectal cancer through targeting PAX6 and regulating PI3K/AKT pathway
    Zhang, Xinli
    Xu, Jumei
    Zhang, Hongchang
    Sun, Jilan
    Li, Na
    Huang, Xianyu
    ONCOLOGY LETTERS, 2020, 19 (06) : 3923 - 3930
  • [5] MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway
    Gao, L. F.
    Jia, S.
    Zhang, Q. M.
    Xia, Y. F.
    Li, C. J.
    Li, Y. H.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (02) : 266 - 275
  • [6] PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway
    Zhao, Gang
    Shi, Xiaobao
    Sun, Zhanbo
    Zhao, Pengfei
    Lu, Zaiming
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (12) : 1602 - 1613
  • [7] SETD1A promotes the proliferation and glycolysis of nasopharyngeal carcinoma cells by activating the PI3K/Akt pathway
    Huang, Jianyi
    Fang, Jinshu
    Xu, Xiao
    Qian, Xueshen
    Zhang, Xia
    OPEN MEDICINE, 2022, 17 (01): : 1849 - 1859
  • [8] MiR-646 regulates proliferation and migration of laryngeal carcinoma through the PI3K/AKT pathway via targeting GPX1
    Yuan, Xuanju
    Liu, Yufeng
    Chen, E.
    Wang, Junhua
    Deng, Shouping
    Chen, Ping
    Wang, Xianhe
    Deng, Shouheng
    ORAL DISEASES, 2021, 27 (07) : 1678 - 1686
  • [9] STAT3-induced ZBED3-AS1 promotes the malignant phenotypes of melanoma cells by activating PI3K/AKT signaling pathway
    Wang, Yang
    Lou, Nan
    Zuo, Min
    Zhu, Fuqiang
    He, Yan
    Cheng, Zhiqiang
    Wang, Xiaomei
    RNA BIOLOGY, 2021, 18 : 355 - 368
  • [10] MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway
    Zhao, Zhidong
    Qin, Xianju
    SCIENTIFIC REPORTS, 2020, 10 (01)